Collectively, these data indicate that sorafenib counteracts TGF-β1-induced EMT and cell migration in A549 adenocarcinoma epithelial cells and provide a possible explanation for its effects with regard to tumor control and reduced cancer metastasis. Here, TGFB1 is linked to cancer.